
Eimear E Kenny, PhD
About Me
Dr. Eimear Kenny, PhD, is a Professor of Medicine and Genetics, and the Founding Director of the Institute for Genomic Health. She leads research at the interface of genomics, medicine, and computer science. She uses data science and massive-scale databases of genomic information to improve human health. Her research spans several different areas, including population and statistical genetics; machine-learning approaches for genomic discovery for rare and common diseases; genomic risk prediction for preventive health; clinical trials in genomic medicine; and digital app development for precision medicine. Her goal is to lead a new paradigm for genomic research embedded in health systems and to enable genomic medicine on a global scale. She is a scientific advisor to many initiatives in government, non-profit and industry arenas.
Language
English
Position
DIRECTOR, INSTITUTE FOR GENOMIC HEALTH, PROFESSOR | Medicine, General Internal Medicine, PROFESSOR | Genetics and Genomic Sciences
Research Topics
Genetics, Genomics
Multi-Disciplinary Training Areas
Disease Mechanisms and Therapeutics (DMT), Neuroscience [NEU]
Video
Education
BSc, Trinity College Dublin
MSc, University of Leeds
PhD, Rockefeller University
Post-doc, Stanford University
Publications
Selected Publications
- Investigating the sources of variable impact of pathogenic variants in monogenic metabolic conditions. Angela Wei, Richard Border, Boyang Fu, Sinéad Cullina, Nadav Brandes, Seon Kyeong Jang, Sriram Sankararaman, Eimear E. Kenny, Miriam S. Udler, Vasilis Ntranos, Noah Zaitlen, Valerie A. Arboleda. Nature Communications
- Rare damaging CCR2 variants are associated with lower lifetime cardiovascular risk. Marios K. Georgakis, Rainer Malik, Omar El Bounkari, Natalie R. Hasbani, Jiang Li, Jennifer E. Huffman, Gabrielle Shakt, Reinier W.P. Tack, Tamara N. Kimball, Yaw Asare, Alanna C. Morrison, Noah L. Tsao, Renae Judy, Braxton D. Mitchell, Huichun Xu, May E. Montasser, Ron Do, Eimear E. Kenny, Ruth J.F. Loos, James G. Terry, John Jeffrey Carr, Joshua C. Bis, Bruce M. Psaty, W. T. Longstreth, Kendra A. Young, Sharon M. Lutz, Michael H. Cho, Jai Broome, Alyna T. Khan, Fei Fei Wang, Nancy Heard-Costa, Sudha Seshadri, Ramachandran S. Vasan, Nicholette D. Palmer, Barry I. Freedman, Donald W. Bowden, Lisa R. Yanek, Brian G. Kral, Lewis C. Becker, Patricia A. Peyser, Lawrence F. Bielak, Farah Ammous, April P. Carson, Michael E. Hall, Laura M. Raffield, Stephen S. Rich, Wendy S. Post, Russel P. Tracy, Kent D. Taylor, Xiuqing Guo, Michael C. Mahaney, Joanne E. Curran, John Blangero, Shoa L. Clarke, Jeffrey W. Haessler, Yao Hu, Themistocles L. Assimes, Charles Kooperberg, Jürgen Bernhagen, Christopher D. Anderson, Scott M. Damrauer, Ramin Zand, Jerome I. Rotter, Paul S. de Vries, Martin Dichgans. Genome Medicine
- Epigenetic mechanisms underlying variation of IL-6, a well-established inflammation biomarker and risk factor for cardiovascular disease. Jessica I. Lundin, Ulrike Peters, Yao Hu, Farah Ammous, Emelia J. Benjamin, Joshua C. Bis, Jennifer A. Brody, Mary Cushman, Harriett Fuller, Chris Gignoux, Xiuqing Guo, Jeff Haessler, Chris Haiman, Roby Joehanes, Silva Kasela, Eimear Kenny, Tuuli Lappalainen, Daniel Levy, Chunyu Liu, Yongmei Liu, Ruth J.F. Loos, Tara Matise, Kari E. North, Sungshim L. Park, Scott M. Ratliff, Alex Reiner, Stephen S. Rich, Jerome I. Rotter, Jennifer A. Smith, Nona Sotoodehnia, Russell Tracy, David Van den Berg, Ting Ye, Wei Zhao, Laura M. Raffield, Charles Kooperberg. Atherosclerosis